HIV continues to affect the health and wellbeing of people in Europe. In 2020, 14,971 new HIV diagnoses were reported in 29 countries of the EU/EEA. This video explain how we can reduce these numbers
Polio is an infectious disease mostly contracted by children. One in two hundred people develop incurable paralysis after infection. In 1955, a vaccine was invented and was introduced on a wide scale. Thanks to global efforts, polio was eliminated from the Western Hemisphere by 1994, and has greatly decreased worldwide.
Depending on the level of evidence provided and the methodology used, this advice is typically conveyed through a Guidance, a Systematic review or an Expert opinion.
In a two-day meeting organised by ECDC and UNAIDS, representatives of 22 European countries discussed how to improve the delivery of HIV pre-exposure prophylaxis (PrEP) across Europe. The meeting brought together country delegates, PrEP users and community HIV advocates to seek ways to strengthen the provision and monitoring of PrEP.
Immunisation is the cornerstone of polio eradication. Two types of vaccine are available: an inactivated poliovirus vaccine (IPV) and a live attenuated OPV.
The conference addressed long-term effectiveness HIV of drugs, co-infections with tuberculosis or viral hepatitis and other co-morbidities, and most inequitable access to care across Europe
Treatment enables people with HIV infection to live a long, healthy and productive life. It also reduces their viral load significantly and this has been shown to be important in preventing onward transmission of HIV.